FDA Inspection 677829 — Diamond Institute for Infertility and Menopause

Diamond Institute for Infertility and Menopause — FEI 3003945103

The FDA completed an inspection of Diamond Institute for Infertility and Menopause on August 18, 2010 in Millburn, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 18, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Millburn, NJ (United States)